Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP11738572Aexternal-prioritypatent/JPS5727114B2/ja
Priority claimed from JP11911372Aexternal-prioritypatent/JPS5727115B2/ja
Priority claimed from JP12663672Aexternal-prioritypatent/JPS5535397B2/ja
Priority claimed from JP8785573Aexternal-prioritypatent/JPS5643472B2/ja
Priority claimed from JP8785173Aexternal-prioritypatent/JPS5641635B2/ja
Priority claimed from JP8785473Aexternal-prioritypatent/JPS5643471B2/ja
Application filed by Fujisawa Pharmaceutical CofiledCriticalFujisawa Pharmaceutical Co
Priority to DK505976ApriorityCriticalpatent/DK505976A/da
Publication of DK505976ApublicationCriticalpatent/DK505976A/da
Analogifremgangsmade til fremstilling af 11-oxygenerede 2-chlor-6alfa,9alfa-difluor-16alfa-methyl-3,20,21-trioxo-1,4-pregnadiener eller 21-aldehydhydrater, -estere eller -acetaler deraf